Bicocca Open Archive

Logo unimib boa
ROTA, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.785
AS - Asia 5.911
EU - Europa 5.539
SA - Sud America 911
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 241
OC - Oceania 20
Totale 26.970
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.960
SG - Singapore 2.188
IT - Italia 1.483
CN - Cina 1.438
RU - Federazione Russa 741
CA - Canada 706
DE - Germania 684
HK - Hong Kong 669
BR - Brasile 663
SE - Svezia 650
VN - Vietnam 648
IE - Irlanda 474
UA - Ucraina 440
GB - Regno Unito 322
FR - Francia 226
IN - India 214
BD - Bangladesh 166
FI - Finlandia 140
ZA - Sudafrica 110
TR - Turchia 89
AR - Argentina 81
NL - Olanda 75
IQ - Iraq 64
AT - Austria 63
KR - Corea 63
DK - Danimarca 55
MX - Messico 51
JP - Giappone 48
EC - Ecuador 42
PK - Pakistan 42
CO - Colombia 39
ES - Italia 39
ID - Indonesia 37
PL - Polonia 36
SA - Arabia Saudita 32
VE - Venezuela 29
MA - Marocco 27
PH - Filippine 27
MY - Malesia 23
BE - Belgio 22
CL - Cile 21
EG - Egitto 18
IR - Iran 18
AE - Emirati Arabi Uniti 17
EU - Europa 16
KE - Kenya 16
CR - Costa Rica 15
JM - Giamaica 15
ET - Etiopia 14
PY - Paraguay 14
TN - Tunisia 14
UZ - Uzbekistan 14
AU - Australia 13
DZ - Algeria 13
JO - Giordania 13
TH - Thailandia 13
GR - Grecia 11
NP - Nepal 11
PE - Perù 11
AZ - Azerbaigian 10
CH - Svizzera 10
CZ - Repubblica Ceca 10
IL - Israele 10
LB - Libano 9
TT - Trinidad e Tobago 9
RO - Romania 8
NO - Norvegia 7
NZ - Nuova Zelanda 6
OM - Oman 6
PR - Porto Rico 6
PS - Palestinian Territory 6
TW - Taiwan 6
UY - Uruguay 6
BG - Bulgaria 5
BH - Bahrain 5
BO - Bolivia 5
KZ - Kazakistan 5
MD - Moldavia 5
NI - Nicaragua 5
A1 - Anonimo 4
HN - Honduras 4
HU - Ungheria 4
LT - Lituania 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
ZM - Zambia 4
AO - Angola 3
GT - Guatemala 3
HR - Croazia 3
KW - Kuwait 3
MN - Mongolia 3
MU - Mauritius 3
SV - El Salvador 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GA - Gabon 2
Totale 26.387
Salva come PNG Salva come JPEG
Città #
Ashburn 1.413
Singapore 1.267
Woodbridge 979
Ann Arbor 953
San Jose 756
Houston 730
Fairfield 661
Hong Kong 652
Chandler 605
Toronto 498
Jacksonville 453
Dublin 451
Milan 418
Dearborn 369
New York 360
Frankfurt am Main 319
Wilmington 319
Santa Clara 288
Seattle 280
Cambridge 258
Council Bluffs 248
Beijing 219
Princeton 201
Dallas 185
Los Angeles 175
Chicago 163
The Dalles 155
Hanoi 146
Ho Chi Minh City 140
Nanjing 138
Shanghai 116
Rome 98
Altamura 95
Lauterbourg 90
Columbus 82
Lawrence 82
Lachine 81
São Paulo 81
Moscow 67
Buffalo 65
Cape Town 61
Hefei 59
Nanchang 59
Guangzhou 57
Dong Ket 55
Vienna 55
San Diego 54
Orem 52
Helsinki 48
Shenyang 48
Boardman 46
Seoul 40
Andover 39
Ottawa 39
Hebei 37
Tianjin 34
Munich 33
Boston 32
Tokyo 32
Jinan 30
Warsaw 30
Washington 30
Manchester 29
Jiaxing 28
Changsha 27
Baghdad 26
Phoenix 26
Brooklyn 25
Hangzhou 25
London 25
Da Nang 24
Denver 24
Zhengzhou 24
Lissone 23
Newark 23
Bologna 22
Montreal 22
Mountain View 22
Philadelphia 22
Atlanta 21
Fremont 21
Haiphong 21
Istanbul 21
San Francisco 21
Johannesburg 20
Chennai 19
Dhaka 19
Irvine 18
Las Vegas 17
Turin 17
Mumbai 16
Nairobi 16
Tampa 16
Guayaquil 15
Norwalk 15
Rio de Janeiro 15
Salt Lake City 15
Valencia 15
Brussels 14
Huizen 14
Totale 16.409
Salva come PNG Salva come JPEG
Nome #
Continuous monitoring of cerebral blood flow (CBF) and cerebral temperature in neurocritical care unit 508
Alcohol consumption and site-specific cancer risk: A comprehensive dose-response meta-analysis 431
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 416
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 382
Intracerebral hemorrhage in intensive care unit: early prognostication fallacies. A single center retrospective study 382
An Effective and Safe Strategy to Target Normothermia in Neurocritical Patients 371
Health related quality of life in chronic liver diseases 360
The impact of liver disease on the health-related quality of life 352
Health Related Quality of Life in the Major Liver Conditions 346
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 344
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage 343
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 341
Organ donation after brain death in refractory cardiac arrest treated with extracorporeal CPR 341
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 339
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 334
A noninvasive index of atrial remodeling in patients with paroxysmal and persistent atrial fibrillation: a pilot study 329
Intracranial pressure monitor insertion in traumatic brain injury: a single center, retrospective decision process analysis 329
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 326
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 320
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 314
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 312
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 312
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 312
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 311
Strong excess risk of pancreatic cancer for low frequency and duration of cigarette smoking: A comprehensive review and meta-analysis 310
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 309
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 309
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies 306
Alcohol drinking and pancreatic cancer risk: a meta-analysis of the dose-risk relation 302
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 302
Difference in health related quality of life of chronic liver diseases and general population 300
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 298
Single-Incision Versus Standard Multiple-Incision Laparoscopic Cholecystectomy: A Meta-analysis of Experimental and Observational Studies 294
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 293
Trajectories of early secondary insults after traumatic brain injury: a new approach to evaluate impact on outcome 293
External Ventricular and Lumbar Drain Device Infections in ICU Patients: A Prospective Multicenter Italian Study 293
Alcohol drinking and risk of renal cell carcinoma: results of a meta-analysis 289
Organ donation in cardiac arrest patients treated with extracorporeal CPR: A single centre observational study 288
Random-effects meta-regression models for studying nonlinear dose-response relationship, with an application to alcohol and esophageal squamous cell carcinoma 286
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 283
Alcohol drinking and laryngeal cancer: Overall and dose-risk relation - A systematic review and meta-analysis 280
Incidence of pain after craniotomy in children 278
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 277
Alcohol drinking and non-Hodgkin lymphoma risk: a systematic review and a meta-analysis 277
Alcohol drinking and multiple myeloma risk - A systematic review and meta-analysis of the dose-risk relationship 275
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 271
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 271
Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: A systematic review and meta-analysis 268
Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products 268
A prospective evaluation of short-term and long-term results from colonic stenting for palliation or as a bridge to elective operation versus immediate surgery for large-bowel obstruction 266
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 265
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 264
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 263
A meta-analysis on alcohol drinking and gastric cancer risk 262
Alcohol drinking and epithelial ovarian cancer risk. A systematic review and meta-analysis 261
Factors influencing the decision to monitor intracranial pressure in traumatic brain injury. A large monocentric study 261
Incidence of inhibitors to recombinant factor VIII products – A meta-analysis of 1,852 previously untreated patients 258
Trajectories of early secondary insults correlate to outcomes of traumatic brain injury: results from a large, single centre, observational study 257
Alcohol consumption and lung cancer risk in never smokers: a meta-analysis 256
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk 253
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation 253
Light alcohol drinking and cancer: a meta-analysis 251
Prospective multicentre cohort study evaluating the incidence of pain after craniotomy in children: first interim analysis. 251
Donor safety in living donor liver donation: An Italian multicenter survey 246
Alcohol drinking and cutaneous melanoma risk: A systematic review and dose-risk meta-analysis 245
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 244
A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 2: Results by subsites 243
A simulation study comparing performance of minimum P-value and Youden index as methods to find optimal cut-points of continuous variables 242
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 242
Cost-effectiveness of Sofosbuvir plus Ledipasvir Antiviral Treatment for Elderly Patients with Chronic Hepatitis C Genotype 1 237
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 236
Alcohol consumption and prostate cancer risk: A meta-analysis of the dose-risk relation 232
Is multifocality a prognostic factor in childhood hepatoblastoma? 232
Thromboembolic event rate in patients exposed to anti-inhibitor coagulant complex: a meta-analysis of 40-year published data 231
Modelling body mass index and endometrial cancer risk in a pooled-analysis of three case-control studies 231
Re: light drinking has positive public health consequences 229
Incidence of Thrombo-Embolic Events in Relation to Activated Prothrombin Complex Concentrate Exposure: A Literature Meta-Analysis 229
Management of Chronic hepatitis C (CHC) Genotype 1 treatment-naive patients in an era of rising opportunities and costs - A cost-effectiveness analysis of treatment options 228
A meta-analysis of alcohol consumption and the risk of brain tumours 225
Cut-pont finding methods for continuous biomarkers 225
A random-effects meta-regression model for studying nonlinear dose-response relationship 220
Finding the optimal cut-point for Gaussian and Gamma distributed biomarkers 217
A meta-analysis on alcohol drinking and the risk of Hodgkin lymphoma 211
Dose-response relationship between cigarette smoking and site-specific cancer risk: Protocol for a systematic review with an original design combining umbrella and traditional reviews 210
Cut-Point Finding Methods For Continuous Biomarkers In The Presence Of Binary And Censored Failure Time Outcome 206
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies 202
Is there a difference in inhibitor incidence with recombinant products? A meta-analysis of 2000 previously untreated patients 198
Quantifying the Dose-Response Relationship Between Circulating Folate Concentrations and Colorectal Cancer in Cohort Studies: A Meta-Analysis Based on a Flexible Meta-Regression Model 198
Alcohol drinking and risk of leukemia-A systematic review and meta-analysis of the dose-risk relation 197
Sofosbuvir and ribavirinin in HCV-infected patients listed for liver transplantation: A cost-effectiveness analysis 196
Optimal cut-point definition in biomarkers: The case of censored failure time outcome 195
Cost-effectiveness of new direct-acting antivirals to prevent post-liver transplant recurrent hepatitis 193
Cut-point identification in biomarkers for a censored failure time outcome 187
Coffee consumption and risk of fractures: A systematic review and dose-response meta-analysis 186
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using “on demand” Approach: A Single Center Experience 185
Safety and Efficacy of Subcutaneous Hepatitis B Immunoprophylaxis using" on demand" Approach: A Single Center Experience 182
Meta-Analysis on Incidence of Inhibitors in 1,945 Previously Untreated Patients Treated with Recombinant Factor VIII Products: Is There a Difference? 169
Cut-point identification in biomarkers for a censored failure time outcome 167
Does alcohol consumption increase the risk of cutaneous melanoma? Comments on a recent meta-analysis: reply from the authors 158
Totale 26.970
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.883
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.883
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022726 0 0 0 98 33 90 29 78 50 84 71 193
2022/20232.189 232 687 171 198 134 338 18 144 178 7 64 18
2023/20241.591 52 69 52 89 174 520 273 75 94 18 16 159
2024/20253.163 227 363 185 127 286 134 164 134 372 448 226 497
2025/20268.351 803 358 586 703 1.009 443 1.078 417 703 787 798 666
2026/20272.228 266 401 917 644 0 0 0 0 0 0 0 0
Totale 26.970